5 December 2014 in International Archives of Otorhinolaryngology
Introduction Radiotherapy or chemoradiotherapy can result in severe swallowing disorders with potential risk for aspiration and can negatively impact the patient's quality of life (QOL). Objective To assess swallowing-related QOL in patients who underwent radiotherapy/chemoradiotherapy for head and neck cancer. Methods We interviewed 110 patients (85 men and 25 women) who had undergone exclusive radiotherapy (25.5%) or concomitant chemoradiotherapy (74.5%) from 6 to 12 months before the study. The Quality of Life in Swallowing Disorders (SWAL-QOL) questionnaire was employed to evaluate dysphagia-related QOL. Results The QOL was reduced in all domains for all patients. The scores were worse among men. There was a relationship between oral cavity as the primary cancer site and the fatigue domain and also between advanced cancer stage and the impact of food selection, communication, and social function domains. Chemoradiotherapy association, the presence of nasogastric tube and tracheotomy, and the persistence of alcoholism and smoking had also a negative effect on the QOL. Conclusions According to the SWAL-QOL questionnaire, the dysphagia-related impact on QOL was observed 6 to 12 months after the treatment ended.
9 September 2019 in Dysphagia
1 January 2019 in Asian Pacific Journal of Cancer Prevention
Objective: To evaluate the effect of induction chemotherapy on swallowing and swallowing-related quality of lifeof patients with oropharyngeal, laryngeal and hypopharyngeal cancer. Study design: Prospective study of 33 patientswith locally advanced tumors who were eligible for treatment with neoadjuvant chemotherapy followed by radiotherapyand concurrent chemotherapy. A multidimensional assessment of swallowing was performed using the followingtools: (1) Clinical analysis, numerical scale for general pain and painful swallowing, American Speech and HearingAssociation (ASHA) Functional Communication Measures (FCM) swallowing assessment scales, (2) assessmentof Swallowing-Related Quality of Life (The MD Anderson Dysphagia Inventory - MDADI), and (3) swallowingvideofluoroscopy. Results: There was a reduction in general pain scale (p=0.021), and quality of life (emotional,functional and physical) improved from average limitation (score of 61-80) to minimal limitation (81-100) afterinduction chemotherapy. According to the swallowing videofluoroscopy results, 26 (78.7%) of the patients had somedegree of dysphagia pre-treatment, which decreased to 21 (63.6%) after induction. Conclusion: Our results suggestthat induction chemotherapy improves numerous aspects of swallowing and has a positive impact on the quality oflife of pre-chemoradiotherapy patients.
1 April 2004 in Clinical Otolaryngology
20 November 2015 in Brazilian Journal of Otorhinolaryngology
EPElio Gilberto Pfuetzenreiter
Elio Gilberto Pfuetzenreiter
ABAna Paula Brandão Barros
Arthritis may affect the larynx and produce symptoms such as hoarseness and vocal fatigue. This paper aimed to evaluate the laryngeal manifestations of rheumatoid arthritis. This is prospective study assessed 27 patients with rheumatoid arthritis with the aid of videolaryngostroboscopy, auditory-perceptual analysis of the speech using the GIRBAS scale, acoustic analysis and the Voice Handicap Index questionnaire. Nineteen patients had laryngeal complaints, the main ones being intermittent dysphonia and sensation of a foreign body in the throat. The most frequent laryngoscopical finding was overlapping arytenoids. Three patients had low pitch, nine patients had mild dysphonia and roughness. Median acoustic measures were: F0, 198.39 Hz; Jitter, 0.815; Shimmer, 4.915; and NHR, 0.144. Regarding the Voice Handicap Index, the median score was zero in all domains. There was a statistically significant correlation between voice complaints and the domains of this index. Functional classes were significantly correlated to: overlapping arytenoids (p = 0.001), PPQ (p = 0.0257), Shimmer (p = 0.0295), APQ (p = 0.0195), and the VHI physical (p = 0.0227) and total domains (p = 0.0425). Laryngeal complaints were reported by 70.4% of the patients and laryngoscopical alterations were observed in 48% of the subjects. Voice acoustic evaluation and self-perception were altered.
18 December 2017 in Einstein (São Paulo)
Objective: Translate to brazilian portuguese, culturally adapt and test the rating and classification scales of cervicofacial lymphedema of the MD Anderson Cancer Center Head and Neck Lymphedema Protocol (MDACC HNL) in patients undergoing treatment for head and neck cancer. Methods: The process followed international guidelines and translation stages by two head and neck surgeons, and back translation independently by two native Americans. The test of final version was based on the evaluation of 18 patients by one speech pathologist and one physical therapist who applied the scales in Portuguese. Results: The translation of the three scales was carried out independently and the translators reached a consensus for the final version. Minor modifications were made by translating two terms into the Assessment of the Face. Versions of back-translation were similar to each other. The instrument was successfully applied to patients independently. Conclusion: The translation and cultural adaptation of the assessment and rating scale of the cervicofacial lymphedema of the MD Anderson Cancer Center Head and Neck Lymphedema Protocol to the Brazilian Portuguese were successful.